Fisher Funds Management LTD Acquires 13,390 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Fisher Funds Management LTD increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 18.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 85,119 shares of the company's stock after buying an additional 13,390 shares during the quarter. Fisher Funds Management LTD's holdings in HCA Healthcare were worth $29,413,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Norges Bank acquired a new stake in HCA Healthcare during the 4th quarter valued at $840,286,000. GAMMA Investing LLC increased its stake in shares of HCA Healthcare by 40,527.3% in the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after buying an additional 1,699,713 shares during the period. Royal London Asset Management Ltd. increased its stake in shares of HCA Healthcare by 62.0% in the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock valued at $450,461,000 after buying an additional 574,239 shares during the period. Barclays PLC increased its stake in shares of HCA Healthcare by 85.7% in the 4th quarter. Barclays PLC now owns 1,061,891 shares of the company's stock valued at $318,727,000 after buying an additional 489,916 shares during the period. Finally, Two Sigma Investments LP increased its stake in shares of HCA Healthcare by 12,016.0% in the 4th quarter. Two Sigma Investments LP now owns 467,437 shares of the company's stock valued at $140,301,000 after buying an additional 463,579 shares during the period. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Down 1.4%

Shares of HCA stock traded down $5.20 on Friday, hitting $372.84. 943,125 shares of the stock were exchanged, compared to its average volume of 1,463,446. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $89.69 billion, a P/E ratio of 16.58, a price-to-earnings-growth ratio of 1.30 and a beta of 1.47. The business has a 50-day moving average of $371.55 and a 200 day moving average of $339.38. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.36 earnings per share. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.77%. HCA Healthcare's payout ratio is presently 12.81%.

Analysts Set New Price Targets

HCA has been the subject of several research reports. Guggenheim started coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Stephens raised HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Morgan Stanley set a $410.00 price objective on HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and lifted their price objective for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Finally, Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Seven research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $395.71.

Insider Transactions at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.